Literature DB >> 6246250

Effect of tunicamycin on herpes simplex virus glycoproteins and infectious virus production.

L I Pizer, G H Cohen, R J Eisenberg.   

Abstract

The antibiotic tunicamycin, which blocks the synthesis of glycoproteins, inhibited the production of infectious herpes simplex virus. In the presence of this drug, [14C]glucosamine and [3H]mannose incorporation was reduced in infected cells, whereas total protein synthesis was not affected. Gel electrophoresis of [2-3H]mannose-labeled polypeptides failed to detect glycoprotein D or any of the other herpes simplex virus glycoproteins. By use of specific antisera we demonstrated that in the presence of tunicamycin the normal precursors to viral glycoproteins failed to appear. Instead, lower-molecular-weight polypeptides were found which were antigenically and structurally related to the glycosylated proteins. Evidence is presented to show that blocking the addition of carbohydrate to glycoprotein precursors with tunicamycin results in the disappearance of molecules, possibly due to degradation of the unglycosylated polypeptides. We infer that the added carbohydrate either stabilizes the envelope proteins or provides the proper structure for correct processing of the molecules needed for infectivity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246250      PMCID: PMC288680     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Effect of 2-deoxy-D-glucose on cell fusion induced by Newcastle disease and herpes simplex viruses.

Authors:  W R Gallaher; D B Levitan; H A Blough
Journal:  Virology       Date:  1973-09       Impact factor: 3.616

2.  Deoxyribonucleic acid synthesis in synchronized mammalian KB cells infected with herpes simplex virus.

Authors:  G H Cohen; R K Vaughan; W C Lawrence
Journal:  J Virol       Date:  1971-06       Impact factor: 5.103

3.  Herpes simplex virus structural proteins.

Authors:  U Olshevsky; Y Becker
Journal:  Virology       Date:  1970-04       Impact factor: 3.616

4.  Proteins specified by herpes simplex virus. 3. Viruses differing in their effects on the social behavior of infected cells specify different membrane glycoproteins.

Authors:  J M Keller; P G Spear; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-04       Impact factor: 11.205

5.  Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion.

Authors:  P G Spear; B Roizman
Journal:  J Virol       Date:  1972-01       Impact factor: 5.103

6.  A temperature-sensitive mutant of herpes simplex virus defective in glycoprotein synthesis.

Authors:  P A Schaffer; R J Courtney; R M McCombs; M Benyesh-Melnick
Journal:  Virology       Date:  1971-11       Impact factor: 3.616

7.  Effects of 2-deoxy-D-glucose on herpes simplex virus replication.

Authors:  R J Courtney; S M Steiner; M Benyesh-Melnick
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

8.  Effect of tunicamycin on the synthesis of macromolecules in cultures of chick embryo fibroblasts infected with Newcastle disease virus.

Authors:  A Takatsuki; G Tamura
Journal:  J Antibiot (Tokyo)       Date:  1971-11       Impact factor: 2.649

9.  Isolation of a herpes simplex virus-specific antigenic fraction which stimulates the production of neutralizing antibody.

Authors:  G H Cohen; M Ponce de Leon; C Nichols
Journal:  J Virol       Date:  1972-11       Impact factor: 5.103

10.  Tunicamycin, a new antibiotic. I. Isolation and characterization of tunicamycin.

Authors:  A Takatsuki; K Arima; G Tamura
Journal:  J Antibiot (Tokyo)       Date:  1971-04       Impact factor: 2.649

View more
  66 in total

1.  Characterization of a recombinant herpes simplex virus which expresses a glycoprotein D lacking asparagine-linked oligosaccharides.

Authors:  D L Sodora; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Absence of asparagine-linked oligosaccharides from glycoprotein D of herpes simplex virus type 1 results in a structurally altered but biologically active protein.

Authors:  D L Sodora; G H Cohen; M I Muggeridge; R J Eisenberg
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Origin of unenveloped capsids in the cytoplasm of cells infected with herpes simplex virus 1.

Authors:  G Campadelli-Fiume; F Farabegoli; S Di Gaeta; B Roizman
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

4.  Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region.

Authors:  R M Stenberg; A S Depto; J Fortney; J A Nelson
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

5.  Localization of epitopes of herpes simplex virus type 1 glycoprotein D.

Authors:  R J Eisenberg; D Long; M Ponce de Leon; J T Matthews; P G Spear; M G Gibson; L A Lasky; P Berman; E Golub; G H Cohen
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

6.  Influence of asparagine-linked oligosaccharides on antigenicity, processing, and cell surface expression of herpes simplex virus type 1 glycoprotein D.

Authors:  D L Sodora; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

7.  Evidence for N-linked glycosylation in Toxoplasma gondii.

Authors:  M Odenthal-Schnittler; S Tomavo; D Becker; J F Dubremetz; R T Schwarz
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

8.  Effect of brefeldin A on alphaherpesvirus membrane protein glycosylation and virus egress.

Authors:  M E Whealy; J P Card; R P Meade; A K Robbins; L W Enquist
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

9.  Brefeldin A arrests the maturation and egress of herpes simplex virus particles during infection.

Authors:  P Cheung; B W Banfield; F Tufaro
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

10.  Processing of N-linked oligosaccharides from precursor- to mature-form herpes simplex virus type 1 glycoprotein gC.

Authors:  F Serafini-Cessi; F Dall'Olio; L Pereira; G Campadelli-Fiume
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.